The SUMO-specific protease SENP2 plays an essential role in the regulation of Kv7.2 and Kv7.3 potassium channels

The SUMO-specific protease SENP2 plays an essential role in the regulation of Kv7.2 and Kv7.3 potassium channels
SENP2 (Sentrin/SUMO-specific protease 2)-deficient mice develop spontaneous seizures in adolescence as a result of a marked discount in M-currents, which regulate neuronal membrane excitability. We now have beforehand proven that hyper-SUMOylation of the Kv7.2 and Kv7.
Three channels is critically concerned within the regulation of the M-currents performed by these potassium voltage-gated channels. Right here we present that hyper-SUMOylation of the Kv7.2 and Kv7.Three proteins decreased binding to the lipid secondary messenger PIP2.
CaM1 has been proven to be tethered to the Kv7 subunits by way of hydrophobic motifs in its C-termini and implicated within the channel meeting. Mutation of the SUMOylation websites on Kv7.2 and Kv7.Three particularly resulted in decreased binding to CaM1 and enhanced CaM1-mediated meeting of Kv7.2 and Kv7.3, whereas hyper-SUMOylation of Kv7.2 and Kv7.
Three inhibited channel meeting. SENP2-deficient mice exhibited elevated acetylcholine ranges within the mind and the center tissue as a result of will increase within the vagal tone induced by recurrent seizures. The SENP2-deficient mice develop seizures adopted by a interval of sinus pauses or AV conduction blocks.
Continual administration of the parasympathetic blocker atropine or unilateral vagotomy considerably extended the lifetime of the SENP2-deficient mice. Moreover, we confirmed that retigabine, an M-current opener, decreased the transcription of SUMO-activating enzyme SAE1 and inhibited SUMOylation of the Kv7.2 and Kv7.Three channels, and in addition extended the lifetime of SENP2-deficient mice.
Taken collectively, the beforehand demonstrated roles of PIP2, CaM1, and retigabine on the regulation of Kv7.2 and Kv7.Three channel operate could be defined by their roles in regulating SUMOylation of this vital potassium channel.

Astragaloside IV alleviates coronary heart failure by regulating SUMO-specific protease 1

The current examine investigated whether or not the protecting impact and mechanism of astragaloside IV (AS-IV) on coronary heart failure (HF) includes small ubiquitin-like modifier (SUMO)-specific protease 1 (Senp1). Mouse HF was established by aortic constriction, inducing strain overload.
The mannequin was confirmed by echocardiography 6 weeks after surgical procedure. Mice had been randomly divided into management, HF, HF+AS-IV, and AS-IV teams. Ventricular operate was examined by echocardiography.
Morphological modifications of myocardial tissues had been examined by H&E staining. The protein ranges of the apoptosis-related proteins, cleaved caspase-3, caspase-3, Bcl2, Bax, and SUMO-Senp1 had been decided by Western blotting. H2O2 in remoted mitochondria and cells was decided by Amplex Crimson.
A reactive oxygen species (ROS) detection package decided ROS ranges in remoted mitochondria and HL-1 cells. JC-1 reagent measured mitochondrial membrane potential (ΔΨm). Apoptosis of HL-1 cells was examined by terminal deoxynucleotidyl transferase dUTP nick finish labeling. In contrast with the management group, the center weight and coronary heart mass/physique weight ratio elevated within the HF group (P<0.05).
Moreover, the ejection fraction and left ventricular shortening fraction decreased (P<0.05), whereas the left ventricular end-diastolic diameter (LVID;d) and end-systolic diameter (LVID;s) elevated (P<0.05). Lastly, mitochondrial ROS and H2O2 elevated (P<0.05), whereas the ΔΨm decreased (P<0.05).
Nevertheless, AS-IV improved the cardiac operate of HF mice, decreased the extent of ROS and H2O2 within the myocardium, suppressed the lower in ΔΨm, and decreased the apoptosis of myocardial cells (P<0.05). AS-IV additionally decreased the Senp1-overexpression.
Moreover, in HL-1 cells, Senp1-overexpression considerably inhibited the protecting results of AS-IV. AS-IV decreased oxidative stress in cardiomyocytes, decreased mitochondrial harm, inhibited ventricular reworking, and finally improved cardiac operate by inhibiting HF-induced Senp1-overexpression. This mechanism gives a novel theoretical foundation and medical remedy for HF.

Dealing With Stress: A Assessment of Plant SUMO Proteases.

The SUMO system is a speedy dynamic post-translational mechanism employed by eukaryotic cells to answer stress. Plant cells expertise hyperSUMOylation of substrates in response to stresses reminiscent of warmth, ethanol, and drought. Many SUMOylated proteins are situated within the nucleus, SUMOylation altering many nuclear processes.
The SUMO proteases play two key features within the SUMO cycle by producing free SUMO; they’ve an vital position in regulating the SUMO cycle, and by cleaving SUMO off SUMOylated proteins, they supply specificity to which proteins change into SUMOylated.
This overview summarizes the broad literature of plant SUMO proteases describing their catalytic exercise, domains and construction, evolution, localization, and response to emphasize and highlighting potential new areas of analysis sooner or later.
 The SUMO-specific protease SENP2 plays an essential role in the regulation of Kv7.2 and Kv7.3 potassium channels

A novel strategy for manufacturing of an energetic N-terminally truncated Ulp1 (SUMO protease 1) catalytic area from Escherichia coli inclusion our bodies.

The SUMO fusion system is extensively used to facilitate recombinant expression and manufacturing of difficult-to-express proteins. After purification of the recombinant fusion protein, removing of the SUMO-tag is completed by the yeast cysteine protease, SUMO protease 1 (Ulp1), which particularly acknowledges the tertiary fold of the SUMO area.
At current, the expression of the catalytic area, residues 403-621, is used for acquiring soluble and biologically energetic Ulp1. Nevertheless, we have now noticed that the soluble and catalytically energetic Ulp1403-621 inhibits the expansion of E. coli host cells.
Within the present examine, we reveal an alternate route for producing energetic Ulp1 catalytic area from a His-tagged N-terminally truncated variant, residues 416-621, which is expressed in E. coli inclusion our bodies and subsequently refolded.
Expressing the insoluble Ulp1416-621 variant is advantageous for attaining increased manufacturing yields. Roughly 285 mg of recombinant Ulp1416-621 was recovered from inclusion our bodies remoted from one liter of excessive cell-density E. coli batch fermentation tradition. After Ni2+-affinity purification of inactive and denatured Ulp1416-621 in 7.5 M urea, totally different refolding situations with various l-arginine focus, pH, and temperature had been examined.
We now have efficiently refolded the enzyme in 0.25 M l-arginine and 0.5 M Tris-HCl (pH 7) at room temperature. Roughly 80 mg of energetic Ulp1416-621 catalytic area could be produced from one liter of excessive cell-density E. coli tradition. We talk about the applicability of inclusion body-directed expression and concerns for acquiring excessive expression yields and environment friendly refolding situations to reconstitute the energetic protein fold.

The Ulp2 SUMO protease promotes transcription elongation by way of regulation of histone sumoylation.

Many eukaryotic proteins are regulated by modification with the ubiquitin-like protein small ubiquitin-like modifier (SUMO). This linkage is reversed by SUMO proteases, of which there are two in Saccharomyces cerevisiae, Ulp1 and Ulp2. SUMO-protein conjugation regulates transcription, however the roles of SUMO proteases in transcription stay unclear.
We report that Ulp2 is recruited to transcriptionally energetic genes to manage native polysumoylation. Mutant ulp2 cells present impaired affiliation of RNA polymerase II (RNAPII) with, and diminished expression of, constitutively energetic genes and the inducible CUP1 gene.
Ulp2 loss sensitizes cells to 6-azauracil, an indicator of transcriptional elongation defects. We additionally describe a novel chromatin regulatory mechanism whereby histone-H2B ubiquitylation stimulates histone sumoylation, which in flip seems to inhibit nucleosome affiliation of the Ctk1 kinase.

EZCut? SUMO Protease 1 Agarose Beads

M1028-5
EUR 588

SUMO-GFP (Multi-Protease Control Protein)

M1072-250
EUR 576

SUMO-GFP (Multi-Protease Control Protein)

M1072-50
EUR 180

Sentrin/SUMO-specific protease (SENP1) polyclonal antibody

ABP-PAB-11087 100 ug Ask for price
    • Product line: Proteases
    • Brand:

EZCut? SUMO Protease 1 (His-tagged), Yeast Recombinant

7868-10000
EUR 2442

EZCut? SUMO Protease 1 (His-tagged), Yeast Recombinant

7868-2500
EUR 648

EZCut? SUMO Protease 1 (His-tagged), Yeast Recombinant

7868-500
EUR 278

EZCut? SUMO Protease 1 (GST-tagged), Yeast Recombinant

7869-100
EUR 157

EZCut? SUMO Protease 1 (GST-tagged), Yeast Recombinant

7869-500
EUR 375

Sentrin/SUMO-specific protease 1 (SENP1) polyclonal antibody

ABP-PAB-10330 100 ug Ask for price
    • Product line: Proteases
    • Brand:

Sentrin/SUMO-specific protease 1 (SENP1) polyclonal antibody

ABP-PAB-10331 100 ug Ask for price
    • Product line: Proteases
    • Brand:

Sentrin/SUMO-specific protease 5 (SENP5, MGC27076) polyclonal antibody

ABP-PAB-10336 100 ug Ask for price
    • Product line: Proteases
    • Brand:

Sentrin/SUMO-specific protease 5 (SENP5, MGC27076) polyclonal antibody

ABP-PAB-10337 100 ug Ask for price
    • Product line: Proteases
    • Brand:

Recombinant Mycoplasma Lon protease Protein, His-SUMO, E.coli-100ug

QP6966-100ug 100ug
EUR 771

Recombinant Mycoplasma Lon protease Protein, His-SUMO, E.coli-10ug

QP6966-10ug 10ug
EUR 355

Recombinant Mycoplasma Lon protease Protein, His-SUMO, E.coli-1mg

QP6966-1mg 1mg
EUR 2531

Recombinant Mycoplasma Lon protease Protein, His-SUMO, E.coli-200ug

QP6966-200ug 200ug
EUR 1224

Recombinant Mycoplasma Lon protease Protein, His-SUMO, E.coli-500ug

QP6966-500ug 500ug
EUR 1614

Recombinant Mycoplasma Lon protease Protein, His-SUMO, E.coli-50ug

QP6966-50ug 50ug
EUR 473

Sentrin/SUMO-specific protease 2, N-terminus (SENP2) polyclonal antibody

ABP-PAB-10332 100 ug Ask for price
    • Product line: Proteases
    • Brand:

Sentrin/SUMO-specific protease 2, C-terminus (SENP2) polyclonal antibody

ABP-PAB-10333 100 ug Ask for price
    • Product line: Proteases
    • Brand:

Sentrin/SUMO-specific protease 3, N-terminus (SENP3) polyclonal antibody

ABP-PAB-10334 100 ug Ask for price
    • Product line: Proteases
    • Brand:

Sentrin/SUMO-specific protease 3, C-terminus (SENP3) polyclonal antibody

ABP-PAB-10335 100 ug Ask for price
    • Product line: Proteases
    • Brand:

Sentrin/SUMO-specific protease 7, N-terminus (SENP7) polyclonal antibody

ABP-PAB-10340 100 ug Ask for price
    • Product line: Proteases
    • Brand:

Sentrin/SUMO-specific protease 7, C-terminus (SENP7) polyclonal antibody

ABP-PAB-10341 100 ug Ask for price
    • Product line: Proteases
    • Brand:

Recombinant Human Serine protease 23 Protein, His-SUMO, E.coli-100ug

QP6538-ec-100ug 100ug
EUR 408

Recombinant Human Serine protease 23 Protein, His-SUMO, E.coli-10ug

QP6538-ec-10ug 10ug
EUR 200

Recombinant Human Serine protease 23 Protein, His-SUMO, E.coli-1mg

QP6538-ec-1mg 1mg
EUR 1632

Recombinant Human Serine protease 23 Protein, His-SUMO, E.coli-200ug

QP6538-ec-200ug 200ug
EUR 634

Recombinant Human Serine protease 23 Protein, His-SUMO, E.coli-500ug

QP6538-ec-500ug 500ug
EUR 1060

Recombinant Human Serine protease 23 Protein, His-SUMO, E.coli-50ug

QP6538-ec-50ug 50ug
EUR 263

Recombinant Human Serine protease HTRA1 Protein, His-SUMO, E.coli-100ug

QP7864-ec-100ug 100ug
EUR 408

Recombinant Human Serine protease HTRA1 Protein, His-SUMO, E.coli-10ug

QP7864-ec-10ug 10ug
EUR 200

Recombinant Human Serine protease HTRA1 Protein, His-SUMO, E.coli-1mg

QP7864-ec-1mg 1mg
EUR 1632

Recombinant Human Serine protease HTRA1 Protein, His-SUMO, E.coli-200ug

QP7864-ec-200ug 200ug
EUR 634

Recombinant Human Serine protease HTRA1 Protein, His-SUMO, E.coli-500ug

QP7864-ec-500ug 500ug
EUR 1060

Recombinant Human Serine protease HTRA1 Protein, His-SUMO, E.coli-50ug

QP7864-ec-50ug 50ug
EUR 263

Recombinant P. aeruginosa Protease LasA Protein, His-SUMO, E.coli-100ug

QP7030-100ug 100ug
EUR 771

Recombinant P. aeruginosa Protease LasA Protein, His-SUMO, E.coli-10ug

QP7030-10ug 10ug
EUR 355
Ctk1 phosphorylates serine-2 (S2) within the RNAPII C-terminal area (CTD) and promotes transcript elongation. Elimination of each ubiquitin and SUMO from histones is required to beat the obstacle to S2 phosphorylation. These outcomes counsel sequential ubiquitin-histone and SUMO-histone modifications recruit Ulp2, which removes polySUMO chains and promotes RNAPII transcription elongation.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post